[HTML][HTML] Comparison of drug switching and discontinuation rates in patients with nonvalvular atrial fibrillation treated with direct oral anticoagulants in the United States
CL Baker, AD Dhamane, J Mardekian, O Dina… - Advances in …, 2019 - Springer
Introduction Continuous usage of direct oral anticoagulants (DOACs) among nonvalvular
atrial fibrillation (NVAF) patients is essential to maintain stroke prevention. We examined …
atrial fibrillation (NVAF) patients is essential to maintain stroke prevention. We examined …
[HTML][HTML] Comparison of Drug Switching and Discontinuation Rates in Patients with Nonvalvular Atrial Fibrillation Treated with Direct Oral Anticoagulants in the United …
CL Baker, AD Dhamane, J Mardekian, O Dina… - Advances in …, 2019 - ncbi.nlm.nih.gov
Methods Patients who initiated apixaban, rivaroxaban, or dabigatran (index event/date)
were identified from the Pharmetrics Plus claims database (Jan 1, 2013–Sep 30, 2016 …
were identified from the Pharmetrics Plus claims database (Jan 1, 2013–Sep 30, 2016 …
[PDF][PDF] Comparison of Drug Switching and Discontinuation Rates in Patients with Nonvalvular Atrial Fibrillation Treated with Direct Oral Anticoagulants in the United …
CL Baker, ADDJ Mardekian, ODCRL Rosenblatt… - 2018 - academia.edu
Introduction: Continuous usage of direct oral anticoagulants (DOACs) among nonvalvular
atrial fibrillation (NVAF) patients is essential to maintain stroke prevention. We examined …
atrial fibrillation (NVAF) patients is essential to maintain stroke prevention. We examined …
Comparison of Drug Switching and Discontinuation Rates in Patients with Nonvalvular Atrial Fibrillation Treated with Direct Oral Anticoagulants in the United States.
CL Baker, AD Dhamane, J Mardekian, O Dina… - Advances in …, 2018 - europepmc.org
Methods Patients who initiated apixaban, rivaroxaban, or dabigatran (index event/date)
were identified from the Pharmetrics Plus claims database (Jan 1, 2013-Sep 30, 2016 …
were identified from the Pharmetrics Plus claims database (Jan 1, 2013-Sep 30, 2016 …
Comparison of Drug Switching and Discontinuation Rates in Patients with Nonvalvular Atrial Fibrillation Treated with Direct Oral Anticoagulants in the United States
CL Baker, AD Dhamane, J Mardekian… - Advances in …, 2019 - pubmed.ncbi.nlm.nih.gov
Introduction Continuous usage of direct oral anticoagulants (DOACs) among nonvalvular
atrial fibrillation (NVAF) patients is essential to maintain stroke prevention. We examined …
atrial fibrillation (NVAF) patients is essential to maintain stroke prevention. We examined …